Gene · 3184
Papers2,430
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,430
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological functions and research progress of eIF4E. | Front Oncol | 2023 | 37601696 | PubTator, text mining | PubMed |
| AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/STAT3 axis. | Cell Mol Life Sci | 2023 | 37589744 | PubTator, text mining | PubMed |
The RNA-binding protein KSRP aggravates malignant progression of clear cell renal cell carcinoma through transcriptional inhibition and post-transcriptional destabilization of the NEDD4L ubiquitin ligase. | J Biomed Sci | 2023 | 37580757 | PubTator, text mining | PubMed |
| Dietary Polyphenols Remodel DNA Methylation Patterns of NRF2 in Chronic Disease. | Nutrients | 2023 | 37571283 | PubTator, text mining | PubMed |
| Phospho-DIGE Identified Phosphoproteins Involved in Pathways Related to Tumour Growth in Endometrial Cancer. | Int J Mol Sci | 2023 | 37569364 | PubTator, text mining | PubMed |
| Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids. | Front Endocrinol (Lausanne) | 2023 | 37560308 | PubTator, text mining | PubMed |
| RBM14 promotes DNA end resection during homologous recombination repair. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37559455 | PubTator, text mining | PubMed |
| Cell-type specific regulator RBPMS switches alternative splicing via higher-order oligomerization and heterotypic interactions with other splicing regulators. | Nucleic Acids Res | 2023 | 37548402 | PubTator, text mining | PubMed |
| A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma. | Front Oncol | 2023 | 37538124 | PubTator, text mining | PubMed |
| PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer. | Front Oncol | 2023 | 37538116 | PubTator, text mining | PubMed |
| Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. | Turk J Biol | 2023 | 37529110 | PubTator, text mining | PubMed |
| Elevated pre-mRNA 3' end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation. | Nat Commun | 2023 | 37528120 | PubTator, text mining | PubMed |
| Hepatitis Delta Virus-Host Protein Interactions: From Entry to Egress. | Viruses | 2023 | 37515216 | PubTator, text mining | PubMed |
| Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons. | Cells | 2023 | 37508559 | PubTator, text mining | PubMed |
| RNA binding protein: coordinated expression between the nuclear and mitochondrial genomes in tumors. | J Transl Med | 2023 | 37507746 | PubTator, text mining | PubMed |
| DHX38 restricts chemoresistance by regulating the alternative pre-mRNA splicing of RELL2 in pancreatic ductal adenocarcinoma. | PLoS Genet | 2023 | 37506056 | PubTator, text mining | PubMed |
| Characterization of epitranscriptome reader proteins experimentally and in silico: Current knowledge and future perspectives beyond the YTH domain. | Comput Struct Biotechnol J | 2023 | 37501707 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. | Front Immunol | 2023 | 37497216 | PubTator, text mining | PubMed |
| The role of cancer-associated fibroblasts in breast cancer metastasis. | Front Oncol | 2023 | 37496657 | PubTator, text mining | PubMed |
| CSDE1 promotes miR-451 biogenesis. | Nucleic Acids Res | 2023 | 37493604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3184/papers?page=10